Evidence map›Paper›PMID 42028272›Full record

ArticleJournal of children's orthopaedics2026

Clinical decision-making in rare bone diseases - A survey among members of the European Paediatric Orthopaedic Society (EPOS) and the European Reference Network on Rare Bone Diseases (ERN BOND).

Thilini H Gamage, Silvia Coutinho, Alberto Leardini, Inês Alves, Nadine Großmann, Ralph Sakkers, Gemma Marcucci, Laura Masi, Maria Luisa Brandi, M Carola Zillikens and 3 more

Abstract read
In one paragraph

Article in Journal of children's orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Thilini H GamageDivision of Orthopaedics, Section of Children's Orthopaedics and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway.ORCID https://orcid.org/0000-0003-1727-2451
Silvia CoutinhoNorwegian Centre for Rare Diseases, Unit Sunnaas, Bjørnemyr, Norway.ORCID https://orcid.org/0000-0003-3791-0967
Alberto LeardiniMovement Analysis Laboratory, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.ORCID https://orcid.org/0000-0003-3547-7370
Inês AlvesANDO Portugal/ European reference Network for Rare Bone Diseases-ERN BOND, Evora, Portugal.ORCID https://orcid.org/0000-0001-8963-4736
Nadine GroßmannFOP e.V.,/International FOP Association (IFOPA)/ European reference Network for Rare Bone Diseases-ERN BOND, Berlin, Germany.ORCID https://orcid.org/0009-0002-6766-8745
Ralph SakkersOrthopaedic Surgery, University Medical Centre Utrecht, Utrecht, the Netherlands.
Gemma MarcucciDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Laura MasiMetabolic Bone Diseases Unit, Musculoskeletal and Rehabilitation Department, University Hospital Careggi, Florence, Italy.
Maria Luisa BrandiFondazione FIRMO Onlus (Italian Foundation for the Research on Bone Diseases), Florence, Italy.
M Carola ZillikensDepartment of Internal Medicine, Erasmus MC, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.ORCID https://orcid.org/0000-0001-9186-3423
Giovanni TrisolinoPediatric Orthopedics and Traumatology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.ORCID https://orcid.org/0000-0002-0361-9920
Lena Lande WekreNorwegian Centre for Rare Diseases, Unit Sunnaas, Bjørnemyr, Norway.
Joachim HornDivision of Orthopaedics, Section of Children's Orthopaedics and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Clinical management of rare bone diseases (RBDs) is challenged by low prevalence, delayed diagnosis, and complex multidisciplinary needs. This survey aimed to map current clinical practices in RBDs, identify unmet needs, and generate foundational data to guide the development of minimum standards for patient assessment. Methods: An anonymous online survey was distributed to members of the European Paediatric Orthopaedic Society (EPOS) and the European Reference Network on Rare Bone Diseases (ERN BOND) in September 2025. Questions addressed diagnostic work-up, interdisciplinary care, transition practices, and future perspectives. Quantitative data were analysed descriptively, and free-text responses thematically. Results: A total of 119 respondents (35 countries), mostly orthopaedic surgeons (74%), completed the survey. Almost all (118/119) provided direct care, and 63% had >10 years' experience treating RBDs. Over 80% routinely used anthropometric, posture, and alignment measures, whereas the use of advanced tools varied. Interdisciplinary care is widely applied at varying frequencies, with a high consideration for shared decision-making and quality of life. Most lacked registry access (>80%) and formal transition protocols (~70%). Respondents prioritised clinical frameworks over technological advances and anticipated increasing future relevance for technological innovations. Conclusions: This survey highlights considerable variability in clinical decision-making for RBDs. The findings underscore the importance and need of standardised interdisciplinary care, registry data, and structured protocols and frameworks. Study Significance: This is the first systematic survey of clinical practice and decision-making process in RBD care among EPOS and ERN BOND members. The findings may guide future recommendations and standards, supporting more harmonised care for individuals with RBDs, especially ultra-rare conditions.

Indexed as

bone disorderClinical practiceclinical practice surveyrare bone diseasesrare diseases

Identifiers

PMID42028272
PMCPMC13099750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.